Hiromu Habashita
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Asymmetric Synthesis and Catalysis, Synthesis and Catalytic Reactions, Synthetic Organic Chemistry Methods, Sphingolipid Metabolism and Signaling
Most-Cited Works
- → Potent, Low-Molecular-Weight Non-Peptide Inhibitors of Malarial Aspartyl Protease Plasmepsin II(1999)169 cited
- → A highly stereoselective synthesis of (E)-alkene dipeptide isosteres via organocyanocopper-Lewis acid mediation reaction(1991)152 cited
- → Novel Low Molecular Weight Spirodiketopiperazine Derivatives Potently Inhibit R5 HIV-1 Infection through Their Antagonistic Effects on CCR5(2001)126 cited
- → A Novel Route to Diastereomerically Pure (E)‐Alkene Dipeptide Isosteres from β‐Aziridinyl‐α,β‐enoates by Treatment with Organocopper Reagents(1994)93 cited
- → Design, Synthesis, and Biological Evaluation of the Combinatorial Library with a New Spirodiketopiperazine Scaffold. Discovery of Novel Potent and Selective Low-Molecular-Weight CCR5 Antagonists(2006)79 cited
- → Aza-Payne Rearrangement of Activated 2-Aziridinemethanols and 2,3-Epoxy Amines under Basic Conditions(1995)64 cited
- → Palladium(0)-Catalyzed Isomerization Reactions of Aziridines Bearing an α,β-Unsaturated Ester Group: A Thermodynamic Preference for Chiral Alkyl (2E)-4,5-cis-4,5-Epimino-N-(alkyl- or arylsulfonyl) 2-Enoates over the Other Three Stereoisomers(1997)62 cited
- → Syn-SN2' pathway in the reaction of certain .gamma.-(mesyloxy) .alpha.,.beta.-enoates with RCu(CN)MgX.BF3 reagents. Importance of MgX and bulky R group upon the diastereoselectivity(1993)53 cited
- → Efficacy and immunomodulatory actions of ONO-4641, a novel selective agonist for sphingosine 1-phosphate receptors 1 and 5, in preclinical models of multiple sclerosis(2012)49 cited
- → Spirodiketopiperazine-based CCR5 antagonists: Lead optimization from biologically active metabolite(2006)47 cited